Stryker, a global leader in medical technologies, has announced the launch of InSpace, the first balloon implant for arthroscopic treatment of massive irreparable rotator cuff tears (MIRCTs), in India. MIRCTs are one of the most common causes of shoulder dysfunction. InSpace provides a new option for surgeons in their shoulder continuum of care that allows them to better meet the needs of their patients.
The InSpace balloon implant is designed to restore the subacromial space without requiring sutures or fixation devices and has been demonstrated to improve shoulder motion and function.
“InSpace is a groundbreaking, first-of-its-kind technology, offering a new, minimally invasive surgical option for surgeons, addressing their unmet needs in MIRCT and potentially providing early functional recovery and pain relief for patients,” said Aman Rishi, Vice President and General Manager for Stryker in India.
On an average, patients showed an increase in range of motion compared to partial repair patients following surgery. It has demonstrated comparable long-term safety and effectiveness results (compared to partial repair) out to two years.
